IRVING, Texas--(BUSINESS WIRE)--Acentrus Specialty™, an Integrated Care Network and health system solution for specialty pharmacy, has signed a new agreement that offers qualified Acentrus hospital and health system clients access to the following Pfizer oncology products: Ibrance® (palbociclib), Bosulif® (bosutinib), Sutent® (sunitinib), Inlyta® (axitinib) and Xalkori® (crizotinib). Pfizer is the first supplier that has been extended an agreement for its limited distribution drug portfolio of oral oncolytics by Acentrus.
“We are very pleased to contract with Pfizer for our first limited distribution drug agreement because it will provide the patients of our health system clients access to these important medications,” said George Zula, Vice President, Acentrus Specialty. “Patients directly benefit by this agreement. We enable health systems to build and grow their specialty pharmacy capabilities so they can retain full visibility to their patients, while delivering care locally. Without access to these medications in this agreement, hospitals would be forced to release the care of their patients outside of their health care delivery system.”
Specialty pharmaceuticals are drugs that require special handling and administration and are often used to treat the most ill and clinically complex patients.
The American Society of Clinical Oncology supports the transformation of a cancer care system that provides a patient-centered care model where the public and private payers, drug suppliers and health providers work together to strengthen the nation’s cancer care delivery system.
Acentrus Specialty, an Apexus solution, supports specialty pharmacy programs within health systems and hospitals, ranging from academic medical centers and community hospitals to integrated delivery networks. Acentrus offers comprehensive services that help these organizations create in-house or outsourced specialty pharmacy operations that integrate and improve care, and enhance patient satisfaction. Acentrus is open to all health systems regardless of GPO affiliation. Pfizer is a leading global pharmaceutical company.
About Acentrus Specialty
Acentrus Specialty is the Integrated Care Network and health system solution for specialty pharmacy, addressing the largest and fastest growing area of health care expenditures by empowering members to deliver exceptional, cost-effective, local integrated care. This is accomplished through a comprehensive, coordinated portfolio of services and specialty pharmacy products, as well as member sharing of clinical and operational best practices. For more information, visit www.acentrusrx.com.
